Neuroreplacement strategies by mesenchymal stem cell

间充质干细胞的神经替代策略

• 批准号: 7255552
• 负责人: KIMINOBU SUGAYA
• 金额: $ 23.73万
• 依托单位: UNIVERSITY OF CENTRAL FLORIDA
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-06-15 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7255552
• 关键词: Adult; Age; Alzheimer' s Disease; Alzheimer' s disease model; Animal Model; Animals; Antibodies; Attention; Autologous Stem Cell Transplantation; Autologous Transplantation; Autopsy; Award; Biological; Biological Process; Bone Marrow; Brain; Brain Diseases; Bromodeoxyuridine; Cell Differentiation process; Cell Lineage; Cell Transplants; Cells; Cholinergic Agents; Coculture Techniques; Condition; DNA Methylation; Data; Detection; Electrons; Fluorescence; Future; Gene Expression; Gene Expression Microarray Analysis; Goals; Grant; Hand; Hippocampus (Brain); Histocompatibility Testing; Human; Immunoglobulin G; Immunohistochemistry; In Vitro; Individual; Injection of therapeutic agent; Investigation; Label; Lesion; Memory; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Microscopic; Modeling; Modification; Mus; Neurodegenerative Disorders; Neurons; Neurotoxins; Nucleus Basalis Magnocellularis; Outcome; Patients; Positioning Attribute; Principal Investigator; Process; Production; Proliferating; Proteins; Qualifying; Range; Rattus; Recovery; Regulation; Replacement Therapy; Reporting; Research; Research Personnel; Residual state; Rodent; Site; Source; Speed; Stem cell transplant; Stem cells; Testing; Therapeutic; Time; Tissues; Toxin; Transfection; Transplantation; adult stem cell; aged; brain tissue; cell motility; cell type; chemotherapy; cholinergic; cholinergic neuron; clinical application; cognitive function; design; experience; expression vector; fetal; ibotenate; improved; in vitro Assay; in vivo; innovation; killings; knowledge base; mature animal; migration; morris water maze; nerve stem cell; programs; relating to nervous system; stem cell fate; stem cell technology; success

DESCRIPTION (provided by applicant): In our previous study, human neural stem cells (HNSCs), proliferated in vitro for more than a year and transplanted into 24-month-old rat brains, migrated and differentiated into neural cells, and significantly improved the cognitive functions of these animals. Although HNSCs are a valuable source of transplantable material as an alternative to fetal neural tissue, the ideal replacement therapies would be the autologous transplantation. Since we have succeeded in producing neural cells from human mesenchymal stem cells (HMeSCs}, we propose the use of HMeSC for neuroreplacement therapies. Our long-range goal is to identify the regulation of the mechanisms of stem cell lineage and to establish neuroreplacement therapy using HMeSCs isolated from individual patients. The central hypothesis of this application is that HMeSCs treated with bromodeoxyuridin (BrdU) produce neural cells that are functionally similar to HNSC-derived cells. The objectives of this project are to find clues for the regulation of mechanisms for stem cell lineage, and to collect basic data for optimal neuroreplacement therapies using HMeSCs. Aim 1. Investigation of the effects of BrdU on neural differentiation of MeSCs. Aim 2. Time-course assessment of HMeSC migration and differentiation after transplantation into the adult brain. Aim 3. To investigate whether MeSC transplantation improves the cognitive functions of aged memory-impaired rats. Aim 4. To investigate whether there is a specific temporal window for efficient neuroreplacement by MeSCs in an Alzheimer's disease lesion model. The proposed research is innovative, because it focuses on the ability of a biological function; i.e., the use of BrdU, to change the lineage of MeSCs, which may facilitate autologous transplantation in neuroreplacement strategies. This proposal is expected to have the following outcomes: (1) a demonstration that BrdU treatment alters HMeSC lineage to produce neural cells in vitro by DNA methylation modification; (2) a demonstration that BrdU-treated HMeSCs differentiate and migrate into their proper position in the adult brain after i.c.v, transplantation; (3) a recovery of cognitive function by HMeSC transplantation in an aged animal model; and (4) a replacement of neurons in an Alzheimer's disease lesion model. The proposed research is expected to provide fundamental data to develop clinical applications for MeSCs transplantation in patients with neurodegenerative diseases through autologus transplantation. Thus, the proposed studies are expected to make a breakthrough in therapeutic strategies.

描述（由申请人提供）： 在我们之前的研究中，人类神经干细胞（HNSCs），在体外增殖一年多，并移植到24个月大的大鼠大脑中，迁移并分化为神经细胞，并显著改善了这些动物的认知功能。虽然HNSCs是一种有价值的可移植材料来源，可替代胎儿神经组织，但理想的替代疗法是自体移植。由于我们已经成功地从人间充质干细胞（HMeSC）产生神经细胞，我们提出将HMeSC用于神经替代疗法。我们的长期目标是确定干细胞谱系机制的调节，并使用从个体患者中分离的HMeSC建立神经替代疗法。本申请的中心假设是用溴脱氧尿苷（BrdU）处理的HMeSC产生功能上类似于HNSC-derived细胞的神经细胞。该项目的目标是寻找干细胞谱系调控机制的线索，并收集使用HMeSCs进行最佳神经替代疗法的基础数据。目标1.研究BrdU对MeSCs神经分化的影响。目标2.移植入成人脑后HMeSC迁移和分化的时程评估。目标3.探讨MeSC移植是否改善老年记忆障碍大鼠的认知功能。目标4。研究在阿尔茨海默病病变模型中是否存在MeSC有效神经替代的特定时间窗。拟议的研究是创新的，因为它侧重于生物功能的能力;即，使用BrdU改变MeSC的谱系，这可能有助于神经替代策略中的自体移植。这一提议预计将具有以下结果：（1）证明BrdU处理通过DNA甲基化修饰改变HMeSC谱系以在体外产生神经细胞;（2）证明BrdU处理的HMeSC在i.c.v移植后分化并迁移到其在成人脑中的适当位置;（3）通过在老年动物模型中移植HMeSC恢复认知功能;和（4）阿尔茨海默病损伤模型中神经元的替代。这项研究有望为通过自体移植在神经退行性疾病患者中开发MeSCs移植的临床应用提供基础数据。因此，拟议的研究有望在治疗策略上取得突破。

项目成果

Bromodeoxyuridine increases multipotency of human bone marrow-derived stem cells.

• 发表时间: 2004
• 期刊: Restorative neurology and neuroscience
• 影响因子: 2.8
• 作者: T. Qu;X. Dong;I. Sugaya;A. Vaghani;J. Pulido;K. Sugaya

Possible use of autologous stem cell therapies for Alzheimer's disease.

• DOI: 10.2174/1567205054367919
• 发表时间: 2005-06
• 期刊: Current Alzheimer research
• 影响因子: 2.1
• 作者: K. Sugaya

How to approach Alzheimer's disease therapy using stem cell technologies.

• DOI: 10.3233/jad-2008-15209
• 发表时间: 2008
• 期刊: Journal of Alzheimer's disease : JAD
• 作者: K. Sugaya;S. Merchant

MCP-1 involvement in glial differentiation of neuroprogenitor cells through APP signaling.

通过应用信号传导，MCP-1参与神经元基因细胞的神经胶质分化。

• DOI: 10.1016/j.brainresbull.2009.01.004
• 发表时间: 2009-04-29
• 期刊: BRAIN RESEARCH BULLETIN
• 影响因子: 3.8
• 作者: Vrotsos, Emmanuel George;Kolattukudy, Pappachan E.;Sugaya, Kiminobu
• 通讯作者: Sugaya, Kiminobu

Amyloid-β precursor protein induces glial differentiation of neural progenitor cells by activation of the IL-6/gp130 signaling pathway.

淀粉样蛋白-β 前体蛋白通过激活 IL-6/gp130 信号通路诱导神经祖细胞的神经胶质分化。

• DOI: 10.1007/s12640-010-9170-6
• 发表时间: 2010
• 期刊: Neurotoxicity research
• 影响因子: 3.7
• 作者: Kwak,Young-Don;Dantuma,Elise;Merchant,Stephanie;Bushnev,Sergey;Sugaya,Kiminobu
• 通讯作者: Sugaya,Kiminobu